Double Plasma Molecular Adsorption System with Sequential Low-dose Plasma Exchange in Patients with Hepatitis B Virus-related Acute-on-chronic Liver Failure: A Prospective Study.

Lu WangWenxiong XuShu ZhuGuoli LinJing LaiYufeng ZhangYing LiuLihua ZhengQiumin LuoZhiliang GaoChan Xie Liang Peng

Published in: Journal of clinical and translational hepatology (2023)

DPMAS+LPE significantly improved the 4-week cumulative survival rate, and ameliorated the inflammatory response in patients. DPMAS+LPE may be a promising modality for patients with early HBV-ACLF.

Keyphrases

liver failure
hepatitis b virus
low dose
inflammatory response
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
clinical trial
high dose
patient reported outcomes
lps induced
toll like receptor
free survival
acute respiratory distress syndrome
study protocol